Stimulation by neurotensin of (3H)5-hydroxytryptamine (5HT) release from rat frontal cortex slices
- PMID: 9845009
- DOI: 10.1016/s0143-4179(98)90073-7
Stimulation by neurotensin of (3H)5-hydroxytryptamine (5HT) release from rat frontal cortex slices
Abstract
The effect of neurotensin (NT) on the K+-evoked (3H)5HT release from brain frontal cortex slices was studied in rats. NT(1-13) and NT(8-13) increased (3H)5HT release with EC50 values in the nanomolar range and Emax values in the range of 100% of control, whereas D-tyr11-NT was inactive. Concerning NT receptor antagonists, SR 48692 and SR 142948A antagonized with IC50 values of 4.8+/-1.8 nM and 4.5+/-1.8 nM respectively, the NT stimulated K+-evoked (3H)5HT release. SR 48527 also antagonized NT induced (3H)5HT release with an IC50 value of 0.95+/-0.06 nM whereas the inactive R(-) enantiomer SR 49711 only inhibited this effect with IC50 value close to 10(-6)M. The 5HT-releasing effect of NT was completely inhibited by tetrodotoxin suggesting that NT receptors involved in the control of 5-HT release are not located on 5-HT terminals. After a first NT (10(-7)M) application, the NT (10(-7)M, 10(-6)M) effect under K+ depolarization was drastically decreased, indicating that the NT receptor could be desensitized. No potentiating effect of NT on K+-evoked (3H)5HT release was observed in striatal and hippocampal slices. These results suggest that, in the rat frontal cortex, NT regulates 5HT release through a high affinity NT receptor not associated with 5HT terminals.
Similar articles
-
Involvement of potentially distinct neurotensin receptors in neurotensin-induced stimulation of striatal [3H]dopamine release evoked by KCl versus electrical depolarization.Neuropharmacology. 1997 Oct;36(10):1447-54. doi: 10.1016/s0028-3908(97)00131-7. Neuropharmacology. 1997. PMID: 9423933
-
Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist.J Pharmacol Exp Ther. 1997 Feb;280(2):802-12. J Pharmacol Exp Ther. 1997. PMID: 9023294
-
SR 48692 inhibits neurotensin-induced [3H]dopamine release in rat striatal slices and mesencephalic cultures.Eur J Pharmacol. 1994 Mar 3;253(3):289-91. doi: 10.1016/0014-2999(94)90204-6. Eur J Pharmacol. 1994. PMID: 8200423
-
Emerging evidence for neurotensin receptor 1 antagonists as novel pharmaceutics in neurodegenerative disorders.Mini Rev Med Chem. 2009 Oct;9(12):1429-38. doi: 10.2174/138955709789957495. Mini Rev Med Chem. 2009. PMID: 19929816 Review.
-
Neurotensin agonists as an alternative to antipsychotics.Expert Opin Investig Drugs. 2005 Apr;14(4):359-69. doi: 10.1517/13543784.14.4.359. Expert Opin Investig Drugs. 2005. PMID: 15882113 Review.
Cited by
-
Chronic, but not acute, dosing of antipsychotic drugs alters neurotensin binding in rat brain regions.Br J Pharmacol. 2000 Nov;131(5):990-6. doi: 10.1038/sj.bjp.0703653. Br J Pharmacol. 2000. PMID: 11053221 Free PMC article.
-
Antinociceptive role of neurotensin receptor 1 in rats with chemotherapy-induced peripheral neuropathy.Korean J Pain. 2020 Oct 1;33(4):318-325. doi: 10.3344/kjp.2020.33.4.318. Korean J Pain. 2020. PMID: 32989196 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials